PharmaEssentia Corporation (LUX:261280523)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD 21.00
-1.00 (-4.55%)
At close: Mar 9, 2026
PharmaEssentia Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,700 | 4,715 | 6,032 | 3,383 | 4,381 | 2,477 | Upgrade
|
| Market Cap Growth | -2.31% | -21.84% | 78.30% | -22.77% | 76.88% | 244.49% | Upgrade
|
| Enterprise Value | 6,109 | 4,154 | 5,449 | 2,800 | 4,274 | 2,462 | Upgrade
|
| Last Close Price | 18.97 | 12.78 | 18.14 | 10.20 | - | - | Upgrade
|
| PE Ratio | 48.96 | 34.45 | 69.04 | - | - | - | Upgrade
|
| PS Ratio | 15.80 | 11.12 | 21.03 | 22.44 | 49.91 | 118.91 | Upgrade
|
| PB Ratio | 7.73 | 5.44 | 7.45 | 4.78 | 11.85 | 18.37 | Upgrade
|
| P/TBV Ratio | 7.78 | 5.48 | 7.53 | 4.84 | 12.08 | 19.50 | Upgrade
|
| P/FCF Ratio | 73.38 | 51.64 | 123.13 | - | - | - | Upgrade
|
| P/OCF Ratio | 46.81 | 32.94 | 81.09 | - | - | - | Upgrade
|
| EV/Sales Ratio | 14.44 | 9.80 | 19.00 | 18.58 | 48.69 | 118.21 | Upgrade
|
| EV/EBITDA Ratio | 42.79 | 30.26 | 100.14 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 45.84 | 31.07 | 106.51 | - | - | - | Upgrade
|
| EV/FCF Ratio | 66.91 | 45.49 | 111.21 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.13 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.16 | 0.16 | 0.47 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.25 | 0.25 | 0.58 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.68 | -0.68 | -0.73 | -0.77 | -0.72 | -0.69 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.32 | -4.32 | -10.88 | 10.12 | 4.57 | 1.08 | Upgrade
|
| Net Debt / FCF Ratio | -6.49 | -6.49 | -12.08 | 9.25 | 4.81 | 1.15 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.33 | 0.24 | 0.27 | 0.11 | Upgrade
|
| Inventory Turnover | 1.29 | 1.29 | 0.86 | 0.48 | 0.83 | 0.60 | Upgrade
|
| Quick Ratio | 5.84 | 5.84 | 9.34 | 9.86 | 4.37 | 2.80 | Upgrade
|
| Current Ratio | 6.21 | 6.21 | 9.94 | 10.64 | 5.24 | 3.49 | Upgrade
|
| Return on Equity (ROE) | 16.97% | 16.97% | 11.54% | -3.46% | -16.77% | -68.81% | Upgrade
|
| Return on Assets (ROA) | 9.00% | 9.00% | 3.72% | -5.61% | -11.77% | -30.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.34% | 56.26% | 26.72% | -43.05% | -85.59% | -210.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.10% | 15.10% | 6.10% | -7.60% | -15.90% | -59.00% | Upgrade
|
| Earnings Yield | 2.04% | 2.90% | 1.45% | -0.54% | -0.96% | -3.60% | Upgrade
|
| FCF Yield | 1.36% | 1.94% | 0.81% | -1.74% | -1.26% | -3.24% | Upgrade
|
| Dividend Yield | 0.09% | 0.23% | 0.16% | - | - | - | Upgrade
|
| Payout Ratio | 7.26% | 7.26% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.13% | -0.13% | -3.58% | -13.47% | -9.24% | -7.39% | Upgrade
|
| Total Shareholder Return | -0.05% | 0.10% | -3.42% | -13.47% | -9.24% | -7.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.